ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Q32 Bio Inc

Q32 Bio Inc (QTTB)

3.23
-0.36
(-10.03%)
Closed December 23 3:00PM
3.2999
0.0699
( 2.16% )
Pre Market: 7:14AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.2999
Bid
3.25
Ask
3.32
Volume
4,916
0.00 Day's Range 0.00
3.02 52 Week Range 53.79
Previous Close
3.23
Open
-
Last Trade
6
@
3.3
Last Trade Time
07:18:41
Average Volume (3m)
294,254
Financial Volume
-
VWAP
-

QTTB Latest News

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2001-5.717142857143.53.773.026744343.35944995CS
4-23.5501-87.709869646226.8528.663.027186646.41316337CS
12-41.5901-92.648919581244.8953.173.0229425414.33427752CS
26-12.2501-78.77877813515.5553.793.0219509321.11202948CS
52-12.9401-79.680418719216.2453.793.0214720221.44406893CS
156-12.9401-79.680418719216.2453.793.0214720221.44406893CS
260-12.9401-79.680418719216.2453.793.0214720221.44406893CS

QTTB - Frequently Asked Questions (FAQ)

What is the current Q32 Bio share price?
The current share price of Q32 Bio is US$ 3.2999
What is the 1 year trading range for Q32 Bio share price?
Q32 Bio has traded in the range of US$ 3.02 to US$ 53.79 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVGRAvinger Inc
US$ 1.81
(181.76%)
49.23M
CREVCarbon Revolution Public Ltd
US$ 9.42
(142.16%)
3.91M
BAOSBaosheng Media Group Holdings Ltd
US$ 3.59
(107.51%)
11.97M
CMNDClearmind Medicine Inc
US$ 2.53
(107.38%)
31.17M
TIVCTivic Health Systems Inc
US$ 0.398
(77.36%)
42.03M
SLGLSol Gel Technologies Ltd
US$ 0.938
(-43.15%)
766.66k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.32
(-31.05%)
2.28k
AGFYAgrify Corporation
US$ 26.525
(-25.89%)
16
GLDDGreat Lakes Dredge and Dock Corporation
US$ 9.01
(-21.96%)
2
KALVKalVista Pharmaceuticals Inc
US$ 7.00
(-20.72%)
184
SVMHSRIVARU Holding Ltd
US$ 0.0344
(22.86%)
161.29M
AVGRAvinger Inc
US$ 1.81
(181.76%)
49.23M
TIVCTivic Health Systems Inc
US$ 0.398
(77.36%)
42.03M
WBUYWeBuy Global Ltd
US$ 0.21
(24.93%)
31.67M
CMNDClearmind Medicine Inc
US$ 2.53
(107.38%)
31.17M